Want to see FR:ERF full AI Analyst Report?
Eurofins Scientific (ERF) Financial Statements
Eurofins Scientific Financial Overview
Eurofins Scientific's market cap is currently $15.44B. The company's EPS TTM is $3.00; its P/E ratio is 29.24; and it has a dividend yield of 0.82%. Eurofins Scientific is scheduled to report earnings on March 2, 2027, and the estimated EPS forecast is $1.61. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 7.30B | $ 6.95B | $ 6.51B | $ 6.71B | $ 6.72B |
| Gross Profit | $ 896.70M | $ 4.71B | $ 620.40M | $ 4.49B | $ 4.57B |
| Operating Income | $ 818.30M | $ 726.20M | $ 546.80M | $ 783.20M | $ 1.28B |
| EBITDA | $ 1.45B | $ 1.39B | $ 1.22B | $ 1.49B | $ 1.88B |
| Net Income | $ 475.00M | $ 406.40M | $ 310.30M | $ 610.20M | $ 782.60M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 791.00M | $ 613.90M | $ 1.22B | $ 486.60M | $ 515.30M |
| Total Assets | $ 10.98B | $ 10.89B | $ 10.89B | $ 10.08B | $ 9.33B |
| Total Debt | $ 5.43B | $ 3.61B | $ 3.93B | $ 3.33B | $ 2.75B |
| Net Debt | $ 4.64B | $ 3.00B | $ 2.71B | $ 2.84B | $ 2.24B |
| Total Liabilities | $ 7.40B | $ 5.50B | $ 5.75B | $ 5.23B | $ 4.66B |
| Stockholders' Equity | $ 3.54B | $ 5.34B | $ 5.08B | $ 4.78B | $ 4.65B |
| Cash Flow | |||||
| Free Cash Flow | $ 535.00M | $ 790.50M | $ 467.80M | $ 476.10M | $ 990.30M |
| Operating Cash Flow | $ 1.29B | $ 1.32B | $ 1.02B | $ 1.14B | $ 1.51B |
| Investing Cash Flow | $ -1.09B | $ -846.50M | $ -681.10M | $ -855.90M | $ -1.03B |
| Financing Cash Flow | $ 13.00M | $ -1.09B | $ 413.60M | $ -311.30M | $ -910.30M |
Currency in EUR